Literature DB >> 17715355

Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle.

Kaiwen Kam1, Roger Nicoll.   

Abstract

The glutamate-glutamine cycle is thought to be integral in continuously replenishing the neurotransmitter pool of glutamate. Inhibiting glial transfer of glutamine to neurons leads to rapid impairment in physiological and behavioral function; however, the degree to which excitatory synaptic transmission relies on the normal operation of this cycle is unknown. In slices and cultured neurons from rat hippocampus, we enhanced the transfer of glutamine to neurons, a fundamental step in this cycle, by adding exogenous glutamine. Although raising glutamine augments synaptic transmission by increasing vesicular glutamate, access to this synthetic pathway by exogenously applied glutamine to neurons is delayed and slow, challenging mechanisms linking the rapid effects of pharmacological inhibitors to decreased vesicular glutamate. We find that pharmacological inhibitors of glutamine synthetase or system A transporters cause an acute depression of basal synaptic transmission that is rapidly reversible, which is unlikely to be attributable to the rapid loss of vesicular glutamate. Furthermore, release of vesicular glutamate remains robust even during the prolonged removal of glutamine from pure neuronal cultures. We conclude that neurons have the capacity to store or produce glutamate for long periods of time, independently of glia and the glutamate-glutamine cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715355      PMCID: PMC6672195          DOI: 10.1523/JNEUROSCI.1198-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α-ketoglutarate for vesicular loading.

Authors:  Kouji Takeda; Atsuhiko Ishida; Kento Takahashi; Tetsufumi Ueda
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

Review 3.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

4.  Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse.

Authors:  Sandip Panicker; Keith Brown; Roger A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

Review 5.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

6.  A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release.

Authors:  Hiroaki Tani; Chris G Dulla; Zoya Farzampour; Amaro Taylor-Weiner; John R Huguenard; Richard J Reimer
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

7.  Good housekeeping.

Authors:  Linda Overstreet-Wadiche; Jacques I Wadiche
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

8.  Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport.

Authors:  Kimberly A Zaia; Richard J Reimer
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

9.  Effective Mechanism for Synthesis of Neurotransmitter Glutamate and its Loading into Synaptic Vesicles.

Authors:  Kouji Takeda; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2016-08-26       Impact factor: 3.996

10.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.